AMS — Advanced Medical Solutions Share Price
Last trade - 00:00- £627.13m
- £564.03m
- £108.60m
- 99
- 18
- 59
- 62
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 26.99 | ||
| PEG Ratio (f) | 2.17 | ||
| EPS Growth (f) | 14.22% | ||
| Dividend Yield (f) | 0.79% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.95 | ||
| Price to Tang. Book | 5.93 | ||
| Price to Free Cashflow | 25.53 | ||
| Price to Sales | 5.77 | ||
| EV to EBITDA | 17.71 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.89% | ||
| Return on Equity | 8.43% | ||
| Operating Margin | 21.18% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 96.91 | 102.6 | 102.37 | 86.8 | 108.6 | 119.02 | 129.93 | 5.46% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +24.11 | +12.37 | -13.76 | -53.14 | +87.69 | +27.51 | +8.03 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Advanced Medical Solutions Group plc is a United Kingdom-based company that specializes in the design, development, manufacture and distribution of tissue-healing technologies, including advanced wound care products, surgical dressings and medical grade materials as well as medical adhesives and sutures for closing and sealing tissue. It manufactures a range of products and materials that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats. The Company operates through two business units for its sales, marketing and research and development (R&D) activities, which include Surgical and Woundcare. Its Surgical business unit is focused on selling and marketing its branded products and are sold directly through its distributors. Its Woundcare business unit is focused on distribution and marketing its products that are supplied to medical device partners under its own brands. The Company offers its products under ActivHeal, LiquiBand and RESORBA brands.
Directors
- Peter Allen NEC
- Andrew Meredith CEO
- Eddie Johnson CFO
- Alan Richardson COO
- Chris Locke CTO
- Cathy Tomlinson DHR
- Simon Coates OTH
- Rose Guang OTH
- Ross McDonald OTH
- Pieter Van-Hoof OTH
- Becky Walmsley OTH
- Owen Bromley SEC
- Grahame Cook NID (63)
- Penelope Freer NID
- Douglas Le Fort NID
- Last Annual
- December 31st, 2021
- Last Interim
- December 31st, 2021
- Incorporated
- November 1st, 1993
- Public Since
- April 30th, 2002
- No. of Employees
- 719
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 216,626,583
- Address
- Premier Park, 33 Road One, WINSFORD, CW7 3RT
- Web
- https://www.admedsol.com/
- Phone
- +44 1606863500
- Contact
- Owen Bromley
- Auditors
- Deloitte LLP
Latest News for AMS
Upcoming Events for AMS
Half Year 2022 Advanced Medical Solutions Group PLC Earnings Release
Similar to AMS
Abingdon Health
London Stock Exchange
Advanced Oncotherapy
London Stock Exchange
Angle
London Stock Exchange
Aptamer
London Stock Exchange
Belluscura
London Stock Exchange
FAQ
As of Today at 13:00 UTC, shares in Advanced Medical Solutions are trading at 289.50p. This share price information is delayed by 15 minutes.
Shares in Advanced Medical Solutions last closed at 289.50p and the price had moved by +3.58% over the past 365 days. In terms of relative price strength the Advanced Medical Solutions share price has outperformed the FTSE All Share Index by +2.51% over the past year.
The overall consensus recommendation for Advanced Medical Solutions is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The Advanced Medical Solutions dividend yield is 0.67% based on the trailing twelve month period.
Last year, Advanced Medical Solutions paid a total dividend of £0.02, and it currently has a trailing dividend yield of 0.67%. We do not have any data on when Advanced Medical Solutions is to next pay dividends.
We do not have data on when Advanced Medical Solutions is to next pay dividends. The historic dividend yield on Advanced Medical Solutions shares is currently 0.67%.
To buy shares in Advanced Medical Solutions you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 289.50p, shares in Advanced Medical Solutions had a market capitalisation of £627.13m.
Here are the trading details for Advanced Medical Solutions:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: AMS
Based on an overall assessment of its quality, value and momentum Advanced Medical Solutions is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Advanced Medical Solutions is 308.43p. That is 6.54% above the last closing price of 289.50p.
Analysts covering Advanced Medical Solutions currently have a consensus Earnings Per Share (EPS) forecast of £0.10 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Advanced Medical Solutions. Over the past six months, its share price has outperformed the FTSE All Share Index by +1.4%.
As of the last closing price of 289.50p, shares in Advanced Medical Solutions were trading -2.9% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Advanced Medical Solutions PE ratio based on its reported earnings over the past 12 months is 26.99. The shares last closed at 289.50p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Advanced Medical Solutions' management team is headed by:
- Peter Allen - NEC
- Andrew Meredith - CEO
- Eddie Johnson - CFO
- Alan Richardson - COO
- Chris Locke - CTO
- Cathy Tomlinson - DHR
- Simon Coates - OTH
- Rose Guang - OTH
- Ross McDonald - OTH
- Pieter Van-Hoof - OTH
- Becky Walmsley - OTH
- Owen Bromley - SEC
- Grahame Cook - NID
- Penelope Freer - NID
- Douglas Le Fort - NID